TickerFactsScreenerDevelopers

Amneal Pharmaceuticals, Inc. (AMRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: $284.88M2017: $245.10M2018: -$19.67M2019: -$248.68M2020: $91.16M2021: $152.72M2022: -$94.93M2023: $204.37M2024: $249.33M2025: $394.10M$394.10M
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$394.10M+58.1%
2024$249.33M+22.0%
2023$204.37M+315.3%
2022-$94.93M-162.2%
2021$152.72M+67.5%
2020$91.16M+136.7%
2019-$248.68M-1164.1%
2018-$19.67M-108.0%
2017$245.10M-14.0%
2016$284.88M—